Patents by Inventor Joong Ho Moon
Joong Ho Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240173277Abstract: The subject invention provides oligo(carbamoylated guanidine)s (OCGs) having fast and selective mycobactericidal effects via disruption of the mycobacterial membrane potential. OCGs also potentiates bedaquiline, an oxidative phosphorylation-targeting anti-TB drug. The combination of OCG and anti-TB drug can be used as an effective therapy for treating tuberculosis.Type: ApplicationFiled: November 10, 2023Publication date: May 30, 2024Applicant: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: JOONG HO MOON, MICHELLE MIRANDA
-
Patent number: 11974972Abstract: The subject invention provides oligo(carbamoylated guanidine)s (OCGs) having fast and selective mycobactericidal effects via disruption of the mycobacterial membrane potential. OCGs also potentiates bedaquiline, an oxidative phosphorylation-targeting anti-TB drug. The combination of OCG and anti-TB drug can be used as an effective therapy for treating tuberculosis.Type: GrantFiled: November 10, 2023Date of Patent: May 7, 2024Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Joong Ho Moon, Michelle Miranda
-
Patent number: 11975077Abstract: A cell-penetrating peptide (CPP) comprising a plurality of mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s where a plurality of the amino acids comprise a positively charged guanylurea unit with a small molecule fragment and each of the mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s comprising a drug attached through a linker. The CPP can be used for treating cancers.Type: GrantFiled: September 17, 2021Date of Patent: May 7, 2024Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventor: Joong Ho Moon
-
Publication number: 20240000732Abstract: The subject invention provides oligo(carbamoylated guanidine)s (OCGs) having fast and selective mycobactericidal effects via disruption of the mycobacterial membrane potential. OCGs also potentiates bedaquiline, an oxidative phosphorylation-targeting anti-TB drug. The combination of OCG and anti-TB drug can be used as an effective therapy for treating tuberculosis.Type: ApplicationFiled: June 30, 2022Publication date: January 4, 2024Applicant: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: JOONG HO MOON, MICHELLE MIRANDA
-
Patent number: 11857521Abstract: The subject invention provides oligo(carbamoylated guanidine)s (OCGs) having fast and selective mycobactericidal effects via disruption of the mycobacterial membrane potential. OCGs also potentiates bedaquiline, an oxidative phosphorylation-targeting anti-TB drug. The combination of OCG and anti-TB drug can be used as an effective therapy for treating tuberculosis.Type: GrantFiled: June 30, 2022Date of Patent: January 2, 2024Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Joong Ho Moon, Michelle Miranda
-
Patent number: 11801228Abstract: The subject invention provides materials and methods for intracellular deliver of molecules and/or therapeutic agents. The subject invention also provides methods for synthesizing polymeric systems and nanomaterials that enhance or assist the passage of molecules and/or therapeutic agents across biological membranes. The compound, polymer or nanoparticle of the subject invention comprises a modified guanidine moiety in a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety comprises, for example, a carbamoyl or thiourea modification. The polymer or nanoparticle can be used in a cancer treatment formulation.Type: GrantFiled: October 13, 2022Date of Patent: October 31, 2023Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Joong Ho Moon, Alfonso Barrios, Mario Diaz
-
Publication number: 20230225982Abstract: The subject invention provides materials and methods for intracellular deliver of molecules and/or therapeutic agents. The subject invention also provides methods for synthesizing polymeric systems and nanomaterials that enhance or assist the passage of molecules and/or therapeutic agents across biological membranes. The compound, polymer or nanoparticle of the subject invention comprises a modified guanidine moiety in a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety comprises, for example, a carbamoyl or thiourea modification. The polymer or nanoparticle can be used in a cancer treatment formulation.Type: ApplicationFiled: October 13, 2022Publication date: July 20, 2023Applicant: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: JOONG HO MOON, ALFONSO BARRIOS, MARIO DIAZ
-
Patent number: 11529315Abstract: The subject invention provides materials and methods for intracellular deliver of molecules and/or therapeutic agents. The subject invention also provides methods for synthesizing polymeric systems and nanomaterials that enhance or assist the passage of molecules and/or therapeutic agents across biological membranes. The compound, polymer or nanoparticle of the subject invention comprises a modified guanidine moiety in a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety comprises, for example, a carbamoyl or thiourea modification. The polymer or nanoparticle can be used in a cancer treatment formulation.Type: GrantFiled: January 19, 2022Date of Patent: December 20, 2022Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Joong Ho Moon, Alfonso Barrios, Mario Milan Diaz
-
Patent number: 11480576Abstract: A phenyleneethynylene macrocycle (PEMC) is constructed that is a cyclic or polycyclic oligo (oligophenyleneethynylene-co-polyamine) where a monodispersed oligophenyleneethynylene is coupled with a polyamine. The PEMC is formed by coupling a monodispersed di-aldehyde end-capped oligophenyleneethynylene with a polyamine to form a macrocyclic imine and reducing the imine to an amine. The PEMC is useful at entering living cells for the fluorescence imaging of the living cells without toxicity to the cells.Type: GrantFiled: June 6, 2019Date of Patent: October 25, 2022Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventor: Joong Ho Moon
-
Publication number: 20220001024Abstract: A cell-penetrating peptide (CPP) comprising a plurality of mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s where a plurality of the amino acids comprise a positively charged guanylurea unit with a small molecule fragment and each of the mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s comprising a drug attached through a linker. The CPP can he used for treating cancers.Type: ApplicationFiled: September 17, 2021Publication date: January 6, 2022Applicant: The Florida International University Board of TrusteesInventor: JOONG HO MOON
-
Patent number: 11123442Abstract: A cell-penetrating peptide (CPP) comprising comprises a plurality of mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s where a plurality of the amino acids comprise a positively charged guanylurea unit with a small molecule fragment and each of the mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s comprising a drug attached through a linker. The CPP can be used for treating cancers.Type: GrantFiled: November 2, 2020Date of Patent: September 21, 2021Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventor: Joong Ho Moon
-
Publication number: 20210128747Abstract: A cell-penetrating peptide (CPP) comprising comprises a plurality of mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s where a plurality of the amino acids comprise a positively charged guanylurea unit with a small molecule fragment and each of the mono(amino acid)s, oligo(amino acid)s, or poly(amino acid)s comprising a drug attached through a linker. The CPP can be used for treating cancers.Type: ApplicationFiled: November 2, 2020Publication date: May 6, 2021Applicant: The Florida International University Board of TrusteesInventor: JOONG HO MOON
-
Patent number: 10868300Abstract: A positive active material for a rechargeable lithium battery including a core including at least one selected from a nickel-based composite oxide represented by Chemical Formula 1 or a lithium manganese oxide represented by Chemical Formula 2; and a coating layer on a surface of the core and including a lithium metal oxide represented by Chemical Formula 3, the positive active material having a peak at a 2? value of about 19° to about 22° and another peak at a 2? value of about 40° to about 45° in an X-ray diffraction pattern using a CuK? ray, is disclosed. A method of preparing the same, and a rechargeable lithium battery including the same, are also disclosed. LiNixCoyMn1-x-yO2??Chemical Formula 1 LiaMnbOc??Chemical Formula 2 Li2MO3??Chemical Formula 3 In Chemical Formulae 1 to 3, x, y, a, b, c, and M are the same as in the detailed description.Type: GrantFiled: May 19, 2014Date of Patent: December 15, 2020Assignee: Samsung SDI Co., Ltd.Inventors: Ming-Zi Hong, Do-Hyung Park, Seon-Young Kwon, Joong-Ho Moon, Ji-Hyun Kim, Han-Eol Park, Min-Han Kim, Myong-A Woo, Ki-Hyun Kim, Jong-Seo Choi
-
Publication number: 20200386763Abstract: A phenyleneethynylene macrocycle (PEMC) is constructed that is a cyclic or polycyclic oligo (oligophenyleneethynylene-co-polyamine) where a monodispersed oligophenyleneethynylene is coupled with a polyamine. The PEMC is formed by coupling a monodispersed di-aldehyde end-capped oligophenyleneethynylene with a polyamine to form a macrocyclic imine and reducing the imine to an amine. The PEMC is useful at entering living cells for the fluorescence imaging of the living cells without toxicity to the cells.Type: ApplicationFiled: June 6, 2019Publication date: December 10, 2020Applicant: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventor: JOONG HO MOON
-
Patent number: 10688189Abstract: A modulated guanidine substituted polymer or nanoparticle has a guanidine moiety or on a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety is modulated as a substituted amidinourea or amidinocarbamate or salt thereof. The modulated guanidine substituted polymer or nanoparticle can be prepared by direct amination of a N-Boc protected guanidine substituted conjugated polymer or N-Boc protected guanidine substituted nanoparticle, where an amine or alcohol is combined in solution or suspension with the protected conjugated polymer or nanoparticle and the resulting mixture is heated. The modulated guanidine substituted polymer or nanoparticle can be used in a cancer treatment formulation.Type: GrantFiled: February 24, 2020Date of Patent: June 23, 2020Assignee: THE FLORIDA INTERNATIONAL BOARD OF TRUSTEESInventors: Joong Ho Moon, Alfonso Barrios
-
Publication number: 20200188520Abstract: A modulated guanidine substituted polymer or nanoparticle has a guanidine moiety or on a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety is modulated as a substituted amidinourea or amidinocarbamate or salt thereof. The modulated guanidine substituted polymer or nanoparticle can be prepared by direct amination of a N-Boc protected guanidine substituted conjugated polymer or N-Boc protected guanidine substituted nanoparticle, where an amine or alcohol is combined in solution or suspension with the protected conjugated polymer or nanoparticle and the resulting mixture is heated. The modulated guanidine substituted polymer or nanoparticle can be used in a cancer treatment formulation.Type: ApplicationFiled: February 24, 2020Publication date: June 18, 2020Applicant: The Florida International University Board of TrusteesInventors: Joong Ho MOON, Alfonso BARRIOS
-
Patent number: 10568902Abstract: A modulated guanidine substituted polymer or nanoparticle has a guanidine moiety or on a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety is modulated as a substituted amidinourea or amidinocarbamate or salt thereof. The modulated guanidine substituted polymer or nanoparticle can be prepared by direct amination of a N-Boc protected guanidine substituted conjugated polymer or N-Boc protected guanidine substituted nanoparticle, where an amine or alcohol is combined in solution or suspension with the protected conjugated polymer or nanoparticle and the resulting mixture is heated. The modulated guanidine substituted polymer or nanoparticle can be used in a cancer treatment formulation.Type: GrantFiled: December 14, 2018Date of Patent: February 25, 2020Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Joong Ho Moon, Md Salauddin Ahmed
-
Publication number: 20190359498Abstract: An active material precursor having a hollow structure is represented by Formula 1: NiaMnbCocMd(OH)2??Formula 1 where, in Formula 1, 0<a?1, 0<b?1, 0<c?1, 0?d?1, and a+b+c=1; and M is at least one metal selected from the group consisting of titanium (Ti) vanadium (V), chromium (Cr), iron (Fe), copper (Cu), aluminum (Al), magnesium (Mg), zirconium (Zr), and boron (B). A method of the active material precursor includes: mixing a nickel precursor, a manganese precursor, a cobalt precursor, a metal (M) precursor, and a solvent to prepare a precursor mixture; and mixing the precursor mixture and a pH adjusting agent to adjust a pH value of the resultant to be in a range of about 11.0 to about 11.2.Type: ApplicationFiled: August 7, 2019Publication date: November 28, 2019Inventors: Joong-Ho Moon, Do-Hyung Park, Min-Han Kim, Ji-Hyun Kim, Seon-Young Kwon, Kyoung-Hyun Kim
-
Patent number: 10483548Abstract: An electron collector structure and a lithium battery including the same are disclosed. The electron collector structure includes a conductive thin film; and a graphene layer that is coated on the surface of the conductive thin film and may improve the electrical conductivity of an electrode plate. As an electrode of the lithium battery includes the electron collector structure, the electrical conductivity of the electrode may be increased so that the energy consumption properties as well as the lifespan characteristics of the lithium battery may be also improved.Type: GrantFiled: June 10, 2014Date of Patent: November 19, 2019Assignee: Samsung SDI Co., Ltd.Inventors: Han-Eol Park, Seon-Young Kwon, Do-Hyung Park, Jong-Seo Choi, Ji-Hyun Kim, Min-Han Kim, Joong-Ho Moon, Kyoung-Hyun Kim
-
Publication number: 20190183923Abstract: A modulated guanidine substituted polymer or nanoparticle has a guanidine moiety or on a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety is modulated as a substituted amidinourea or amidinocarbamate or salt thereof. The modulated guanidine substituted polymer or nanoparticle can be prepared by direct amination of a N-Boc protected guanidine substituted conjugated polymer or N-Boc protected guanidine substituted nanoparticle, where an amine or alcohol is combined in solution or suspension with the protected conjugated polymer or nanoparticle and the resulting mixture is heated. The modulated guanidine substituted polymer or nanoparticle can be used in a cancer treatment formulation.Type: ApplicationFiled: December 14, 2018Publication date: June 20, 2019Applicant: The Florida International University Board of TrusteesInventors: Joong Ho Moon, Md Salauddin Ahmed